24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
aMoon
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:44
Teva to pay $450 million over Copaxone price inflation
15:02
Asus Zenbook S 14 embraces AI revolution with Intel's Core Ultra Processor
14:46
Hezbollah missiles threaten Adani's Haifa Port: What happens if Israel’s key trade hub shuts down?
12:57
TechnoPulm raises $2 million to develop a handheld device capable of performing full lung function tests
More stories
Buzz
Most popular
Daily
Weekly
1
Intel employees brace for layoff notices as cuts to move into high gear next week
2
"We’ll be looking out for you": Intel CEO Gelsinger stands with Israeli team
3
Bill Ackman sees 80% return on Tel Aviv Stock Exchange investment in just 10 months
4
Prime Security nets $6 million in Seed to build guardrails into the software design phase
5
Snyk cuts losses by a third, boosts revenue by 50%, as it prepares for IPO
More news
aMoon
20 stories about aMoon
Seizing the HealthTech opportunity: Early-stage innovation takes center stage
29.04.24
|
Dr. Yaron Daniely
"As investment activity fluctuates and new challenges emerge, investors find themselves at a critical juncture," writes Dr. Yaron Daniely, General Partner at aMoon Fund
Israeli healthtech startups raised $2.8 billion in 2022, but tech crisis threatens growth
17.04.23
|
CTech
While healthtech is not immune to the overall macroeconomic environment, it proved to be more resilient in 2022, with capital raised in the sector declining by just 13% compared to other high-tech sectors which experienced a collective decline of 43%
“I once got asked who is home with my kids, it’s an offensive question a man would never be asked”
15.02.23
|
Noa Gadot
Brachie Sprung, Chief Communications Officer & Head of IR at healthtech and life sciences investment fund aMoon, has always been the underdog, but that only made her more hungry for success
"When we look at investment, it is first and foremost a money decision. But we also look to make the world a better place"
11.12.22
|
James Spiro
A panel of physicians and VCs gathered during The Future Health Matrix in Tel Aviv held by the Israel Medical Association (IMA) to discuss investment opportunities in the future of medicine
“Global spend on healthcare is, by and large, recession-proof”
11.12.22
|
Elihay Vidal, James Spiro
aMoon Velocity’s Roy Wiesner and Yaniv Sadka joined CTech to share some predictions for the year ahead.
Life sciences VC aMoon raises $340 million for second fund
20.07.22
|
Meir Orbach
aMoon Growth II will focus on later-stage investments and will support entrepreneurs and scientists developing solutions combining biology with AI, Big Data, and other advanced technologies
aMoon raising new massive healthtech fund
21.10.21
|
Meir Orbach
The Israeli life sciences VC didn't reveal the magnitude of the new fund, but it is expected to be in the region of its previous $750 million fund
Eleos Health raises $6 million Seed funding to accelerate clinicians' decision-making
13.09.21
|
CTech
The Israeli startup’s AI-powered Speech-to-Insights system for clinicians aims to provide more accessible, efficient, personalized and time and cost-effective care
Israel’s aMoon fund saw a 15-fold return on its investment in Seer
09.12.20
|
Sophie Shulman
aMoon invested in the U.S. biomed company when it was valued at $228 million- after a Nasdaq IPO, its value ballooned to $3.5 billion
Yair Schindel: aMoon’s healthtech anchor
30.11.20
|
CTech
Schindel’s aMoon fund has invested in 38 tech companies in Israel, the U.S. and recenly in Europe too
Israel’s aMoon leads $110 million funding round in SOPHiA GENETICS
04.10.20
|
Hagar Ravet
The new funding aims to boost the medtech company’s penetration in both the U.S. and Asian markets
Israel’s aMoon leads funding rounds in U.S. and European companies
10.09.20
|
Hagar Ravet
The healthtech VC led a $35 million round in MOBILion and a $30 million round in MiNA Therapeutics
Roche, aMoon to launch early-stage innovation program
10.08.20
|
Hagar Ravet
The program is scheduled to run for the next three years, with three companies set to be selected and receive investments each year
Which fund topped out at $750 million and how much money did Check Point make?
22.07.20
|
CTech
CTech Daily Roundup: Covid-19 and no flights mean more money for Check Point as Q2 profits soar
Israeli healthtech VC aMoon Velocity invests $6 million in Nectin Therapeutics
15.07.20
|
James Spiro
Nectin Therapeutics places antibodies in proteins known to cause cancer, improving immune systems and blocking certain checkpoints
Nacht’s aMoon raising new fund to invest in early stage companies
22.06.20
|
Hagar Ravet
Velocity Fund has already invested in NanoGhosts, Vocalis Health, and IBEX
Healthtech Is Israel’s Next Growth Engine, Says Venture Capitalist
21.02.20
|
Sophie Shulman
Yair Schindel was a decorated army medic, a doctor, an entrepreneur, and the head of Israel’s National Digital Bureau. Now, he manages Israeli venture capital fund aMoon and wants to turn Israel into a healthtech empire
Life Sciences Venture Fund aMoon Invests $5 Million in Cancer Drug Company
24.12.19
|
Hagar Ravet
NanoGhosts turns stem cells into a drug delivery system that specifically targets cancerous tumors
Marius Nacht’s aMoon Leads $55 Million Round in Healthtech Company Seer
17.12.19
|
Hagar Ravet
Seer develops technology for extracting molecular insights from cell proteome, to assist in the early detection of cancer and neurological diseases
Newly Merged Voice Analysis Startups Healthymize and Beyond Verbal Raise $9 Million
10.12.19
|
Hagar Ravet
The new entity, Vocalis Health, will develop technology for the voice-based analysis and detection of health issues such as heart and respiratory conditions and depression
More Articles
Please ensure Javascript is enabled for purposes of
website accessibility